Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Memory | 18 | 2017 | 21 | 3.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 21 | 2022 | 111 | 2.870 |
Why?
|
| Oncolytic Virotherapy | 2 | 2023 | 3 | 1.000 |
Why?
|
| Melanoma | 2 | 2023 | 49 | 0.890 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2017 | 36 | 0.850 |
Why?
|
| Dengue | 1 | 2023 | 1 | 0.800 |
Why?
|
| Dengue Virus | 1 | 2023 | 1 | 0.800 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 2 | 0.800 |
Why?
|
| Mice | 21 | 2023 | 1249 | 0.660 |
Why?
|
| Animals | 25 | 2023 | 3301 | 0.640 |
Why?
|
| Interleukin-15 | 2 | 2022 | 8 | 0.580 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 13 | 0.560 |
Why?
|
| Cell Movement | 5 | 2017 | 77 | 0.550 |
Why?
|
| Mucous Membrane | 1 | 2017 | 23 | 0.530 |
Why?
|
| Models, Immunological | 2 | 2014 | 4 | 0.490 |
Why?
|
| Adoptive Transfer | 4 | 2012 | 30 | 0.460 |
Why?
|
| Intestinal Mucosa | 3 | 2014 | 157 | 0.440 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 11 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 362 | 0.400 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2012 | 14 | 0.390 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2012 | 94 | 0.380 |
Why?
|
| Mammaglobin A | 1 | 2012 | 2 | 0.370 |
Why?
|
| Whole-Body Irradiation | 1 | 2012 | 9 | 0.370 |
Why?
|
| Cell Differentiation | 5 | 2017 | 124 | 0.330 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2010 | 1 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 375 | 0.290 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 93 | 0.280 |
Why?
|
| Neoplasms | 2 | 2022 | 219 | 0.280 |
Why?
|
| Lymphocyte Activation | 6 | 2010 | 76 | 0.260 |
Why?
|
| Listeriosis | 3 | 2004 | 3 | 0.250 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 175 | 0.240 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 3 | 2012 | 4 | 0.240 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 66 | 0.230 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 17 | 0.220 |
Why?
|
| Immunotherapy | 2 | 2023 | 50 | 0.200 |
Why?
|
| Immunity | 1 | 2023 | 10 | 0.200 |
Why?
|
| MCF-7 Cells | 1 | 2023 | 15 | 0.200 |
Why?
|
| Cell Death | 1 | 2023 | 34 | 0.200 |
Why?
|
| Lung | 6 | 2019 | 140 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 47 | 0.200 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2012 | 15 | 0.190 |
Why?
|
| Interferon-gamma | 4 | 2012 | 72 | 0.190 |
Why?
|
| Th2 Cells | 1 | 2002 | 15 | 0.180 |
Why?
|
| Dendritic Cells | 3 | 2012 | 28 | 0.180 |
Why?
|
| Th1 Cells | 1 | 2002 | 23 | 0.180 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 162 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2017 | 388 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 9 | 0.160 |
Why?
|
| T-Box Domain Proteins | 2 | 2017 | 4 | 0.160 |
Why?
|
| L-Selectin | 2 | 2012 | 7 | 0.160 |
Why?
|
| Injections, Intralesional | 1 | 2019 | 28 | 0.160 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2017 | 6 | 0.150 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 10 | 0.150 |
Why?
|
| Humans | 9 | 2023 | 23207 | 0.140 |
Why?
|
| Lymphoid Tissue | 4 | 2007 | 10 | 0.140 |
Why?
|
| Cell Communication | 2 | 2009 | 21 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 246 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 3 | 0.130 |
Why?
|
| Sirolimus | 1 | 2017 | 20 | 0.130 |
Why?
|
| Liver | 4 | 2007 | 135 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 7 | 0.130 |
Why?
|
| Influenza, Human | 2 | 2019 | 40 | 0.130 |
Why?
|
| Oncogenes | 1 | 2016 | 11 | 0.130 |
Why?
|
| Virus Diseases | 2 | 2014 | 10 | 0.120 |
Why?
|
| Lymphocytes | 2 | 2007 | 51 | 0.120 |
Why?
|
| Vaccines, DNA | 2 | 2012 | 6 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2011 | 278 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2007 | 144 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2014 | 11 | 0.110 |
Why?
|
| Vagina | 1 | 2014 | 31 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2014 | 31 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2014 | 47 | 0.100 |
Why?
|
| CD40 Ligand | 2 | 2004 | 7 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2016 | 166 | 0.100 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 2 | 0.090 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2012 | 4 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2012 | 39 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 35 | 0.090 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2012 | 7 | 0.090 |
Why?
|
| Lymphocyte Count | 2 | 2010 | 16 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2007 | 100 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 163 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2011 | 3 | 0.090 |
Why?
|
| Proteins | 1 | 2011 | 52 | 0.080 |
Why?
|
| Immunophenotyping | 2 | 2007 | 28 | 0.080 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Transgenes | 1 | 2010 | 10 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 16 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2006 | 8 | 0.070 |
Why?
|
| Female | 3 | 2014 | 13147 | 0.070 |
Why?
|
| Granzymes | 1 | 2007 | 7 | 0.070 |
Why?
|
| HIV Infections | 1 | 2012 | 439 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 5 | 0.060 |
Why?
|
| Borrelia burgdorferi | 1 | 2007 | 1 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 91 | 0.060 |
Why?
|
| Treponema pallidum | 1 | 2007 | 4 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 87 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2007 | 20 | 0.060 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Monocytes | 1 | 2007 | 38 | 0.060 |
Why?
|
| Interleukin-7 | 1 | 2006 | 13 | 0.060 |
Why?
|
| Immunity, Cellular | 2 | 2019 | 33 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 528 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2005 | 10 | 0.060 |
Why?
|
| Cell Separation | 1 | 2005 | 21 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2005 | 25 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2007 | 463 | 0.060 |
Why?
|
| Vesicular stomatitis Indiana virus | 3 | 2014 | 5 | 0.060 |
Why?
|
| Models, Biological | 1 | 2005 | 302 | 0.050 |
Why?
|
| Clonal Anergy | 1 | 2003 | 2 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2003 | 13 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2003 | 14 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2003 | 41 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2003 | 20 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 294 | 0.050 |
Why?
|
| Mouth | 1 | 2002 | 12 | 0.050 |
Why?
|
| Apoptosis | 1 | 2003 | 196 | 0.050 |
Why?
|
| Kinetics | 1 | 2002 | 176 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2022 | 71 | 0.040 |
Why?
|
| Cytokines | 1 | 2002 | 192 | 0.040 |
Why?
|
| Squalene | 1 | 2019 | 2 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 4 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 11 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 19 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 17 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 26 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2019 | 33 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 49 | 0.040 |
Why?
|
| Skin | 1 | 2019 | 117 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2016 | 18 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 163 | 0.030 |
Why?
|
| Listeria monocytogenes | 2 | 2006 | 3 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 539 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 19 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 12 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2012 | 22 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 180 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2011 | 1 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2011 | 14 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2011 | 9 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 1 | 2011 | 6 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 99 | 0.020 |
Why?
|
| HIV-1 | 1 | 2012 | 203 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 260 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 277 | 0.020 |
Why?
|
| Vesiculovirus | 1 | 2009 | 1 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Vesicular Stomatitis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2009 | 3 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2009 | 8 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2009 | 10 | 0.020 |
Why?
|
| G1 Phase | 1 | 2009 | 16 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 18 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 70 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 40 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 130 | 0.020 |
Why?
|
| Male | 1 | 2023 | 12662 | 0.020 |
Why?
|
| Arenaviridae Infections | 1 | 2007 | 1 | 0.020 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2007 | 4 | 0.020 |
Why?
|
| Serum | 1 | 2007 | 5 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2006 | 6 | 0.020 |
Why?
|
| Splenectomy | 1 | 2006 | 6 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2007 | 18 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2007 | 40 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 20 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2007 | 45 | 0.020 |
Why?
|
| Stem Cells | 1 | 2006 | 34 | 0.020 |
Why?
|
| Cell Line | 1 | 2007 | 244 | 0.020 |
Why?
|
| Rhabdoviridae Infections | 1 | 2004 | 1 | 0.010 |
Why?
|
| Parabiosis | 1 | 2004 | 2 | 0.010 |
Why?
|
| Respirovirus Infections | 1 | 2004 | 1 | 0.010 |
Why?
|
| Rotavirus Infections | 1 | 2004 | 1 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 2004 | 2 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 49 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2004 | 30 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 2003 | 3 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2003 | 4 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 11 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 80 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 26 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2003 | 1 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 5 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 4 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 12 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 11 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2003 | 12 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 125 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 11 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1264 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 1241 | 0.010 |
Why?
|